Gilead (GILD) is planning to invest $11B in the U.S. to bolster its domestic manufacturing and research, Reuters reports. The investments will supplement $21B in U.S. manufacturing and R&D through 2030, according to the report. Gilead will invest in new technology, build three new facilities and upgrade three existing sites, Reuters says.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Gilead announces new Livdelzi data at EASL
- Gilead announces final results from MYR301 study
- Gilead put volume heavy and directionally bearish
- Gilead Sciences: Hold Rating Maintained Amid Near-Term Challenges and Limited Growth Prospects
- U.S. attorney announces $202M settlement with Gilead over kickbacks
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue